(Q33155841)

22 July 2017

title

Significant decrease in nelfinavir systemic exposure after omeprazole coadministration in healthy subjects (English)

1 reference

22 July 2017

1 reference

1 reference

6

1 reference

22 July 2017

Annie F Fang

1

1 reference

22 July 2017

Bharat D Damle

2

1 reference

22 July 2017

Robert R LaBadie

3

1 reference

22 July 2017

Penelope H Crownover

4

1 reference

22 July 2017

Dial Hewlett

5

1 reference

22 July 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

22 July 2017

1 reference

22 July 2017

volume

28

1 reference

22 July 2017

issue

1

1 reference

22 July 2017

page(s)

42-50

1 reference

An update and review of antiretroviral therapy

22 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Review: mixing new cocktails: drug interactions in antiretroviral regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Nelfinavir: a review of its use in the management of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Nelfinavir: an update on its use in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: structural identification, levels in plasma, and antiviral activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Conversion of the HIV protease inhibitor nelfinavir to a bioactive metabolite by human liver CYP2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Effects of esomeprazole on the pharmacokinetics of atazanavir and fosamprenavir in a patient with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Pharmacokinetics of saquinavir co-administered with cimetidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Lack of effect of gastric acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: consequences for FK506 assimilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

Variable expression of CYP and Pgp genes in the human small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.42

21 January 2018

Identifiers

DOI

10.1592/PHCO.28.1.42

1 reference

22 July 2017

1 reference